Additional studies should explore molecular or epigenetic mechanisms underlying the therapeutic effects of GA on diabetes-related dysfunction; especially, its role in adipogenesis, insulin signaling, and oxidative damage within adipocytes or hepatocytes should be examined. The gene discussed is INS; the disease is diabetes mellitus.